Joel Isaacson & Company Has Cut Cvs Health (CVS) Holding as Share Value Declined; White Elm Capital Boosted Autodesk (ADSK) Holding by $2.05 Million as Market Valuation Rose

April 17, 2018 - By David Stenberg

Autodesk, Inc. (NASDAQ:ADSK) Logo

Joel Isaacson & Company Llc decreased its stake in Cvs Health Corp (CVS) by 11.4% based on its latest 2017Q4 regulatory filing with the SEC. Joel Isaacson & Company Llc sold 5,041 shares as the company’s stock declined 17.45% with the market. The institutional investor held 39,188 shares of the medical and nursing services company at the end of 2017Q4, valued at $2.84 million, down from 44,229 at the end of the previous reported quarter. Joel Isaacson & Company Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $67.12B market cap company. The stock increased 4.21% or $2.67 during the last trading session, reaching $66.1. About 19.01M shares traded or 120.33% up from the average. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 17, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Matthew Iorio increased its stake in Autodesk Inc (ADSK) by 10.05% based on its latest 2017Q4 regulatory filing with the SEC. White Elm Capital Llc bought 19,700 shares as the company’s stock rose 23.51% while stock markets declined. The hedge fund run by Matthew Iorio held 215,800 shares of the technology company at the end of 2017Q4, valued at $22.62 million, up from 196,100 at the end of the previous reported quarter. White Elm Capital Llc who had been investing in Autodesk Inc for a number of months, seems to be bullish on the $28.32 billion market cap company. The stock increased 0.43% or $0.55 during the last trading session, reaching $129.72. About 1.44M shares traded. Autodesk, Inc. (NASDAQ:ADSK) has risen 50.18% since April 17, 2017 and is uptrending. It has outperformed by 38.63% the S&P500.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 75 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Buy” rating by Mizuho on Thursday, June 23. The rating was upgraded by Vetr on Monday, August 24 to “Buy”. The firm earned “Hold” rating on Monday, December 12 by Jefferies. The firm has “Hold” rating given on Friday, October 27 by Robert W. Baird. The stock has “Buy” rating by Oppenheimer on Tuesday, August 8. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Tuesday, November 7 by Leerink Swann. On Thursday, October 6 the stock rating was initiated by UBS with “Buy”. The company was downgraded on Wednesday, August 16 by Wolfe Research. On Friday, January 5 the stock rating was upgraded by Morgan Stanley to “Overweight”. Jefferies maintained CVS Health Corporation (NYSE:CVS) on Friday, September 15 with “Hold” rating.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.80 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

Investors sentiment decreased to 0.72 in Q4 2017. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Gillespie Robinson & Grimm accumulated 303,406 shares or 2.78% of the stock. Credit Suisse Ag invested in 1.85M shares or 0.12% of the stock. Keybank National Association Oh reported 399,830 shares stake. New Mexico Educational Retirement Board, New Mexico-based fund reported 97,687 shares. Glenmede Trust Na reported 489,012 shares. Mckinley Carter Wealth Serv has invested 0.08% in CVS Health Corporation (NYSE:CVS). Bancorporation Pictet Cie (Asia) Ltd holds 1.44% of its portfolio in CVS Health Corporation (NYSE:CVS) for 45,730 shares. Willingdon Wealth Mgmt holds 0.44% or 18,371 shares. Art Advsr Ltd Liability Corporation accumulated 93,000 shares. 2.65M are held by Thomaspartners. Advantus Capital Mngmt reported 101,974 shares or 0.18% of all its holdings. Lvw Ltd Liability Com accumulated 0.66% or 31,103 shares. The Germany-based Lingohr & Partner Asset Mgmt Gmbh has invested 1.15% in CVS Health Corporation (NYSE:CVS). Cypress Capital Mgmt Limited Liability Company holds 0.06% or 4,510 shares in its portfolio. 8,120 are owned by Phocas Fin Corp.

Since February 16, 2018, it had 0 insider buys, and 1 sale for $1.42 million activity.

Among 27 analysts covering Autodesk Inc. (NASDAQ:ADSK), 18 have Buy rating, 3 Sell and 6 Hold. Therefore 67% are positive. Autodesk Inc. had 124 analyst reports since August 4, 2015 according to SRatingsIntel. Canaccord Genuity maintained Autodesk, Inc. (NASDAQ:ADSK) on Tuesday, March 6 with “Buy” rating. The stock of Autodesk, Inc. (NASDAQ:ADSK) earned “Buy” rating by Robert W. Baird on Wednesday, November 29. Guggenheim maintained the stock with “Buy” rating in Wednesday, November 29 report. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, December 7. On Monday, February 22 the stock rating was maintained by Barclays Capital with “Overweight”. The stock has “Outperform” rating by William Blair on Friday, August 28. The firm earned “Buy” rating on Thursday, February 15 by Cowen & Co. Evercore maintained the stock with “Buy” rating in Wednesday, August 23 report. The stock of Autodesk, Inc. (NASDAQ:ADSK) has “Neutral” rating given on Friday, August 26 by UBS. The firm has “Mixed” rating given on Thursday, August 3 by OTR Global.

White Elm Capital Llc, which manages about $1.86 billion and $473.62M US Long portfolio, decreased its stake in Paypal Hldgs Inc by 43,800 shares to 198,700 shares, valued at $14.63 million in 2017Q4, according to the filing. It also reduced its holding in Transdigm Group Inc (NYSE:TDG) by 22,600 shares in the quarter, leaving it with 68,961 shares, and cut its stake in Visa Inc (NYSE:V).

Investors sentiment decreased to 1.08 in Q4 2017. Its down 0.34, from 1.42 in 2017Q3. It worsened, as 46 investors sold ADSK shares while 171 reduced holdings. 84 funds opened positions while 151 raised stakes. 204.78 million shares or 0.77% less from 206.38 million shares in 2017Q3 were reported. Assetmark holds 265 shares or 0% of its portfolio. Citigroup accumulated 116,551 shares. Planning Advsrs Ltd Liability has 5,118 shares for 0.19% of their portfolio. Stephens Inc Ar owns 20,139 shares or 0.08% of their US portfolio. 114,306 were accumulated by Aperio Gp Ltd Liability. The Massachusetts-based Panagora Asset Management has invested 0% in Autodesk, Inc. (NASDAQ:ADSK). Nomura Asset Ltd stated it has 28,508 shares. Moreover, Pictet Asset Management has 0.22% invested in Autodesk, Inc. (NASDAQ:ADSK) for 834,312 shares. Minnesota-based Sit Investment Assoc has invested 0.11% in Autodesk, Inc. (NASDAQ:ADSK). Srs Management Ltd Liability Co has 21,200 shares for 0.06% of their portfolio. Blackrock Incorporated reported 16.81 million shares stake. Capital Advisers Ltd Liability Corporation reported 21,897 shares or 0.02% of all its holdings. First Manhattan has 275 shares. Waddell And Reed holds 0.19% or 795,962 shares. Eminence Cap Lp reported 1.91M shares.

Autodesk, Inc. (NASDAQ:ADSK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: